NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
03/24/2026
Back to search
Official data from USPTO
WORLD LYMPHEDEMA DAY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
WORLD LYMPHEDEMA DAY
ST13
US500000086903310Class
35
Filing
86903310
Registration
5066187
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
03/25/2026
Trademark type
Word
Nice classes
35
Filing date
02/10/2016
Registration date
10/18/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2026
Last transaction
03/25/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
02/02/2016
First use in commerce
02/02/2016
Drawing code
4
Owner type
03
Owner location
New York, NY, US
Examiner
MARCY, AMY ALFIERI
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Lymphatic Research Foundation, Inc.
Representatives
Philip Y. Braginsky Tarter Krinsky & Drogin LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Public advocacy to promote awareness of lymphedema; promoting public awareness of the need for research and development in the field of lymphedema
Publications
History of USPTO decisions and trademark events.
39 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
03/24/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
03/24/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/23/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
01/08/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/18/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
05/03/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
05/03/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/03/2023
ES8R
TEAS SECTION 8 RECEIVED
10/04/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/18/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/17/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/17/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/17/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/17/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/17/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/09/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/09/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/09/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/09/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/09/2020
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
10/18/2016
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/13/2016
ALIE
ASSIGNED TO LIE
09/12/2016
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
08/23/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/20/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/19/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/19/2016
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
08/16/2016
IUAA
USE AMENDMENT ACCEPTED
08/15/2016
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
08/12/2016
IUAF
USE AMENDMENT FILED
08/12/2016
EAAU
TEAS AMENDMENT OF USE RECEIVED
08/11/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/06/2016
GNRT
NON-FINAL ACTION E-MAILED
06/06/2016
CNRT
NON-FINAL ACTION WRITTEN
06/06/2016
DOCK
ASSIGNED TO EXAMINER
05/26/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/17/2016
NWAP
NEW APPLICATION ENTERED
02/13/2016
Continuous trademark protection
Get notified about every new filing that threatens WORLD LYMPHEDEMA DAY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.